These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2667764)

  • 1. Expression of the H-ras proto-oncogene is controlled by alternative splicing.
    Cohen JB; Broz SD; Levinson AD
    Cell; 1989 Aug; 58(3):461-72. PubMed ID: 2667764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the 2719 mutant of the c-H-ras oncogene in a bi-intronic alternative splicing system.
    Guil S; Darzynkiewicz E; Bach-Elias M
    Oncogene; 2002 Aug; 21(36):5649-53. PubMed ID: 12165864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A splicing enhancer in the 3'-terminal c-H-ras exon influences mRNA abundance and transforming activity.
    Hwang DY; Cohen JB
    J Virol; 1997 Sep; 71(9):6416-26. PubMed ID: 9261359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene.
    Cohen JB; Levinson AD
    Nature; 1988 Jul; 334(6178):119-24. PubMed ID: 3133569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21H-ras-induced morphological transformation and increases in c-myc expression are independent of functional protein kinase C.
    Lloyd AC; Paterson HF; Morris JD; Hall A; Marshall CJ
    EMBO J; 1989 Apr; 8(4):1099-104. PubMed ID: 2663469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.
    Liang H; Atkins H; Abdel-Fattah R; Jones SN; Lunec J
    Gene; 2004 Sep; 338(2):217-23. PubMed ID: 15315825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation in vitro of H-ras oncogene expression by trans-splicing.
    Codony C; Guil S; Caudevilla C; Serra D; Asins G; Graessmann A; Hegardt FG; Bach-Elias M
    Oncogene; 2001 Jun; 20(28):3683-94. PubMed ID: 11439331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for the mutation of ras gene in psoriatic epidermis.
    Takahashi H; Iizuka H; Katagiri M
    Arch Dermatol Res; 1990; 282(1):8-11. PubMed ID: 2180382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate N-ras mRNA up-regulation with mutational activation in tumorigenic guinea pig cells.
    Doniger J; DiPaolo JA
    Nucleic Acids Res; 1988 Feb; 16(3):969-80. PubMed ID: 3278301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-ras oncogene is activated in a human medulloblastoma cell line.
    Fults D; Maness PF; Nakamura Y; White R
    Brain Res; 1989 Dec; 503(2):281-7. PubMed ID: 2691018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature sensitivity of aberrant RNA splicing with a mutation in the G+5 position of intron 37 of the gene for type III procollagen from a patient with Ehlers-Danlos syndrome type IV.
    Wu Y; Kuivaniemi H; Tromp G; Strobel D; Romanic AM; Prockop DJ
    Hum Mutat; 1993; 2(1):28-36. PubMed ID: 8477261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the neuron-specific alternative splicing product of the c-src proto-oncogene.
    Raulf F; Robertson SM; Schartl M
    J Neurosci Res; 1989 Sep; 24(1):81-8. PubMed ID: 2478722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
    Saez R; Chan AM; Miki T; Aaronson SA
    Oncogene; 1994 Oct; 9(10):2977-82. PubMed ID: 8084601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis.
    Kwong YY; Husain Z; Biswas DK
    Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.